Skip to main content
. 2022 Aug 21;19(10):1502–1509. doi: 10.7150/ijms.73947

Figure 8.

Figure 8

Conclusion of this study. Luteolin blocks PM2.5-induced EGFR-PI3K-AKT signaling and subsequently reduces the expression of MMP-2 and ICAM-1. Therefore, the migration ability of human lung cancer H460 cells is inhibited. Collectively, luteolin is considered as a potent therapy of lung cancer progression.